?

Altshuler David

EVP, Chief Scientific Officer
Vertex Pharmaceuticals Incorporated
US, Boston [HQ]
CIK 1550395

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
25,813
Price per Share :
$419.92
Equivalence :
$10,839,394.96

Transaction History

  • S
    Form 4
    25,813 Shares After Transaction
    Value : $12,353,069.28
    Sold $7,178.40
    11/15/24
  • Footnotes:
    #1 Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024.
  • S
    Form 4
    34,022 Shares After Transaction
    Value : $14,349,458.94
    Sold $1,266,153.54
    02/21/24
  • F
    Form 4
    43,838 Shares After Transaction
    Value : $18,587,750.38
    $1,590,037.50
    02/16/24
  • F
    Form 4
    41,026 Shares After Transaction
    Value : $17,254,715.08
    $1,182,670.96
    02/20/24
  • S
    Form 4
    37,024 Shares After Transaction
    Value : $15,579,328.96
    Sold $1,684,001.58
    02/20/24

Get PRO Today.

PRO unlocks 8 more insider transactions made by Altshuler David

Start Free PRO trial Subscribe to PRO